To help launch the Cornell Center for Immunology, world-renowned immunologist Mark Davis traveled Cornell University in early September to to give a talk and meet faculty and students. He attended a luncheon for postdoctoral researchers and graduate students from a variety of fields including four who are participants in the National Institutes of Health T32 Training Grant.|
Stanford University Immunologist Dr. Mark M. Davis has been selected as a Fall 2019 University Lecturer. His lecture, “Standing on the Shoulders of Mice: Rebooting Human Immunology” will take place on Monday, September 9 at 4:00pm in Lecture Hall 4/5, College of Veterinary Medicine. This lecture is free and open to the public.
The latest edition of the Journal of Virology featured a study by Hector Aguilar-Carreno details how two highly lethal viruses, Nipah and Hendra, have greater pathogenic potential when their cell-sabotaging proteins are combined. Aguilar-Carreno’s lab is also working on related research that may lead to vaccine-free therapies or improved vaccines to treat enveloped viruses, which include infectious diseases such as HIV and influenza.
The Cancer Research Institute’s “Lloyd J. Old Scientists Taking Risks (STAR) program” recognizes immunologists who are conducting high-risk, high-reward research in tumor immunology. Dr. Gregory Sonnenberg is one of five scientists to receive a $1.25 million, five-year grant, to explore disruptive and uncommon cancer research paths following an international competition.
Pediatric Rheumatologist Virginia Pascual, Drukier Director of the Gale and Ira Drukier Institute for Children’s Health at Weill Cornell Medicine, is featured in featured in the May 2019 EZRA faculty spotlight.
A molecule that helps prevent fat accumulation in mammals is produced within fat tissues by stem-like cells that may be therapeutic targets for obesity and related disorders, according to a new study. Obesity increases the risk of other major diseases including cancers, heart disease, diabetes and immunological disorders.
Hailed as “transformative” and “a historic achievement” by faculty members, a strategic investment of close to $2 million directed by Provost Michael Kotlikoff has improved Cornell’s capabilities in flow cytometry, which is pivotal in cell research.
Helen Su, a clinical immunologist who has made key discoveries into the genetic causes of rare immune system diseases in children, has been awarded the fourth annual Gale and Ira Drukier Prize in Children’s Health Research by Weill Cornell Medicine. The Drukier Prize honors an early-career pediatrician whose research has made important contributions toward improving the health of children and adolescents.
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccines. The study is the first to explore the interrelationship among nanomaterials, immune responses and the microbiome, an increasingly important area of research.
Carl Nathan, chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine, has been awarded the institution’s Joan and Sanford I. Weill Exemplary Achievement Award. The award recognizes outstanding faculty members whose transformational work enhances health and health care worldwide.